Chengdu Huasun Technology Group Co Ltd
SZSE:000790
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Chengdu Huasun Technology Group Co Ltd
Revenue
Chengdu Huasun Technology Group Co Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
Chengdu Huasun Technology Group Co Ltd
SZSE:000790
|
Revenue
¥545.5m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
2%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥15B
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥32.6B
|
CAGR 3-Years
15%
|
CAGR 5-Years
2%
|
CAGR 10-Years
13%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥41.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Revenue
¥22.3B
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
19%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Revenue
¥2.5B
|
CAGR 3-Years
53%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
Chengdu Huasun Technology Group Co Ltd
Glance View
Chengdu Huasun Technology Group Inc., Ltd. specializes in the research and development, manufacture, and sale of Chinese and Western medicines as well as biopharmaceutical products. The company is headquartered in Chengdu, Sichuan and currently employs 647 full-time employees. The firm primarily provides Chinese medicines, Western medicines, biological drugs, veterinary drugs and veterinary biological vaccines, as well as modern steel structures. Its pharmaceutical products include oral liquid, capsules, biological products and veterinary drugs, among others. The firm operates its businesses primarily in the China domestic market, with Sichuan province as its main market.
See Also
What is Chengdu Huasun Technology Group Co Ltd's Revenue?
Revenue
545.5m
CNY
Based on the financial report for Dec 31, 2025, Chengdu Huasun Technology Group Co Ltd's Revenue amounts to 545.5m CNY.
What is Chengdu Huasun Technology Group Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was -37%. The average annual Revenue growth rates for Chengdu Huasun Technology Group Co Ltd have been -15% over the past three years , -6% over the past five years , and 2% over the past ten years .
